The Kim Lab provides consulting on preclinical studies, first-in-human proof-of-concept studies, and randomized clinical trials. We also give guidance on new therapeutic launches and marketing of emerging treatments.
The Kim Lab has unique expertise in basic approaches and techniques in innate immunity, neuroimmunology, and behavioral modelling of chronic itch. Therefore, we are able to provide state of the art guidance on in vitro, ex vivo, and in vivo experimental systems to better understand skin immunity, inflammation, and sensation.Read more
Mechanistic cellular and molecular studies in the Kim Lab are efficiently tested and validated in human cells and tissues. Further, we employ preclinical modelling of human disease to test candidate targets, pathways, and drugs to quickly inform drug development. Thus, we are able to provide expertise in early stage drug development to biotechnology companies and […]Read more
Dr. Kim has designed a number of phase 2 clinical trials for atopic dermatitis and chronic itch. Thus, we are able to provide expertise in trial design along with employing translational assays to capture correlative biomarkers. We are continuously focused on designing new and innovative trials to champion the development of new and better treatments […]Read more
The Itch Clinic sees many different forms of chronic itch disorders. As a result, we have discovered new genetic mutations, syndromes, and diseases that present as chronic itch. Thus, we have opportunities to discover new disorders and develop novel diagnostics for various chronic itch disorders.Read more